Şeyma Ateşoğlu

Exploring highly selective polymethoxy fenamate isosteres as novel anti-prostate cancer agents: Synthesis, biological activity, molecular docking, molecular dynamics, and ADME studies

Feyzi Sinan Tokalı, Halil Şenol, Şeyma Ateşoğlu et al. · Journal of Molecular Structure · 2024 · 40 citations

Medicinal Chemistry, Biochemistry, Polymer-drug Conjugate +10

A series of quinazolin‐4(<scp><i>3H</i></scp>)‐one‐morpholine hybrids as anti‐lung‐cancer agents: Synthesis, molecular docking, molecular dynamics, <scp>ADME</scp> prediction and biological activity studies

Feyzi Sinan Tokalı, Halil Şenol, Şeyma Ateşoğlu et al. · Chemical Biology & Drug Design · 2024 · 35 citations

Aldose reductase inhibition properties of novel thiazolidin-2,4-diones: In vitro and in silico approach for the treatment of diabetes-related complications

Feyzi Sinan Tokalı, Yeliz Demir, Halil Şenol et al. · Journal of Molecular Liquids · 2025 · 25 citations

Metabolic Syndrome, Aldo-keto Reductase, Biochemistry +8

Novel 4-((3-fluorobenzyl)oxy)benzohydrazide derivatives as promising anti-prostate cancer agents: Synthesis, characterization and in vitro &amp; in silico biological activity studies

Furkan Çakır, Şeyma Ateşoğlu, Aytekin Köse et al. · Journal of Molecular Structure · 2024 · 23 citations

Medicinal Chemistry, Anti-prostate Cancer Agents, Derivative (Chemistry) +8

Development of phenolic Mannich bases as α-glucosidase and aldose reductase inhibitors: In vitro and in silico approaches for managing diabetes mellitus and its complications

Feyzi Sinan Tokalı, Yeliz Demir, Şeyma Ateşoğlu et al. · Bioorganic & Medicinal Chemistry · 2025 · 23 citations